Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Fmoc-D-Asparagine

    • Product Name Fmoc-D-Asparagine
    • Alias FMOC-ASN
    • Einecs 607-033-3
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    125072

    Product Name Fmoc-D-Asparagine
    Chemical Formula C19H17N3O5
    Molecular Weight 367.36 g/mol
    Cas Number 153046-39-6
    Appearance White to off-white powder
    Purity ≥98%
    Storage Temperature 2-8°C
    Solubility DMSO, DMF, slightly soluble in methanol
    Optical Activity D-configuration (dextrorotatory)
    Protecting Group Fmoc (9-fluorenylmethyloxycarbonyl)
    Synonyms Fmoc-D-Asn-OH
    Application Peptide synthesis
    Stability Stable under recommended storage conditions
    Hazard Classification Non-hazardous

    As an accredited Fmoc-D-Asparagine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Packaged in a 5-gram amber glass bottle, Fmoc-D-Asparagine is securely sealed with a tamper-evident cap and labeled.
    Shipping Fmoc-D-Asparagine is shipped in secure, airtight packaging to maintain stability and prevent contamination. The product is typically transported at ambient or controlled room temperature unless otherwise specified. Accompanied by a certificate of analysis and safety documents, Fmoc-D-Asparagine complies with all relevant chemical shipping regulations and standards.
    Storage **Fmoc-D-Asparagine** should be stored in a tightly sealed container, protected from light and moisture. Keep it in a cool, dry place, typically at 2–8°C (refrigerator temperature). Ensure the storage area is well-ventilated and that the chemical is kept away from incompatible substances, such as strong oxidizers. Proper storage maintains the compound’s integrity and prevents degradation.
    Application of Fmoc-D-Asparagine

    Applications of Fmoc-D-Asparagine in Industrial Manufacturing

    Fmoc-D-Asparagine is a specialized amino acid derivative essential in advanced peptide synthesis. As a direct manufacturer, we focus on strict process control and quality stability to support downstream sectors requiring high-purity protected amino acids. Below, we detail the principal industrial applications where this raw material features as a critical input, outlining specific technical parameters relevant to each segment.

    1. Solid Phase Peptide Synthesis for Research-Grade and GMP-Grade Peptides

    Fmoc-D-Asparagine is widely used in the automated solid-phase synthesis of custom peptides, including D-amino acid containing sequences for pharma R&D, diagnostic markers, and preclinical peptide candidates. The protected D-asparagine residue ensures precise integration and stereochemical stability during resin-bound stepwise elongation, supporting synthesis protocols demanded by regulated environments.

    Industry compliance standards

    • ICH Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients
    • USP Chapter <1047> and EP 5.4: Peptide Substances
    • EudraLex Volume 4: Annex 13 GMP for IMPs (where relevant)
    • ISO 9001:2015 for quality management in research peptide supply

    Typical usage ratio

    • Integrated into synthesis resins at a molar ratio of 1:1 for the designated sequence position; overall loading typically 0.1–0.5 mmol per gram of resin, adjusted based on target peptide length and resin swelling characteristics.

    Downstream process integration

    • Coupling stage following Fmoc deprotection within automated peptide synthesizers using standard HBTU/HATU activation cycles or microwave-assisted processes.

    Final product types

    • Custom research peptides
    • Preclinical active peptide pharmaceutical intermediates
    • Chimeric peptide-based diagnostic reagents
    • D-enantiomeric reference standards for analytical labs

    2. Manufacturing of Peptide-Based Drug Candidates (API Production)

    In the advanced pharmaceutical sector, Fmoc-D-Asparagine serves as a protected building block in multi-step synthesis of investigational and commercial D-amino acid peptides, which offer enhanced resistance to proteolytic enzymes and improved bioavailability. The product’s defined stereochemistry and controlled impurity profile support strict regulatory batch release for early-phase and commercial-scale API manufacturing.

    Industry compliance standards

    • FDA 21 CFR Part 210/211 (Current Good Manufacturing Practice for Finished Pharmaceuticals)
    • European Pharmacopoeia (Ph. Eur.) 10th Edition monographs on peptide APIs
    • ICH Q3A/B: Impurities in New Drug Substances and Products
    • PIC/S GMP Guide PE 009-15

    Typical usage ratio

    • Stoichiometric equivalence for defined residue within API; product feed is often 0.75–1.2 equivalents per coupling cycle, depending on target yield and process validation results.

    Downstream process integration

    • Residue-specific integration in solid phase and solution-phase synthesis reactors during peptide elongation, prior to global deprotection and purification steps (RP-HPLC, preparative chromatography).

    Final product types

    • D-peptide active pharmaceutical ingredients (APIs)
    • Anticancer and antimicrobial peptide therapeutics
    • API intermediates for orphan drug manufacturing
    • Enzyme-resistant peptide analogs

    3. Production of Synthetic Peptide Standards for Mass Spectrometry and Bioanalysis

    Reference-grade Fmoc-D-Asparagine is a key input for synthesis of custom-labeled peptides and D-amino acid internal standards demanded by analytical labs and contract testing organizations. High purity and accurate mass yields improve calibration assurance for LC-MS/MS and MALDI-TOF quantitative workflows, essential in both clinical and food contaminant testing sectors.

    Industry compliance standards

    • ISO/IEC 17025:2017 Laboratory Testing and Calibration Requirements
    • FDA Bioanalytical Method Validation Guidance for Industry
    • Sigma Aldrich and NIST Peptide Standard Reference Guidelines
    • GLP (Good Laboratory Practices), OECD Principles

    Typical usage ratio

    • Calculated based on target peptide standard’s chain length; commonly 1 μmol to 10 μmol scale per batch, with Fmoc-D-Asparagine introduced once per relevant sequence position.

    Downstream process integration

    • Incorporation into sequence during first-stage automated peptide synthesis, followed by isotopic labeling (if applicable) and purification prior to lyophilization or solution calibration.

    Final product types

    • Synthetic peptide calibration standards
    • Stable isotope-labeled peptide internal standards
    • Peptide reference materials for environmental and clinical quantitation
    • Quality control peptides for LC-MS and immunoassay kit manufacturing

    4. Preparation of Modified Peptides for Structural Bioengineering and Peptide Functionalization

    D-enantiomeric asparagine–based building blocks enable production of structurally modified peptides, especially for applications in nanoscale self-assembly, biomedical scaffolds, or functionalization of novel biomaterials. These bespoke materials require high-precision Fmoc-protected D-amino acids to introduce site-specific functional groups and achieve designed physicochemical profiles confirmed by downstream characterization.

    Industry compliance standards

    • ISO 13485:2016 for biomaterial process quality (when used for medical device R&D)
    • USP General Chapter <1043> Ancillary MaterialsUsed in Cell, Gene, and Tissue-Engineered Products
    • REACH (EC 1907/2006) preregistration for synthetic intermediates
    • Internal laboratory QC protocols (bioengineering sector)

    Typical usage ratio

    • Custom molar incorporation depending on target peptide scaffold design; typically 0.2–1 mmol/gram resin, matched to precise site-functionalization or sequence motif frequency.

    Downstream process integration

    • Automated solid-phase synthesis incorporation at designated modification points, followed by orthogonal deprotection and chemical attaching reactions (e.g., fluorophore conjugation, PEGylation, nanoparticle linkage).

    Final product types

    • Functionalized self-assembling peptide hydrogels
    • Peptide-polymer conjugates for drug delivery
    • Nano-scale peptide-based biomaterials
    • Peptide-encoded beads for affinity screening
    Free Quote

    Competitive Fmoc-D-Asparagine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing Fmoc-D-Asparagine: Reliable Performance for Peptide Synthesis

    Grounded in Experience: The Value We Bring to Labs

    Every batch of Fmoc-D-Asparagine we produce reflects the practical challenges of modern peptide chemistry. Years spent scaling up from gram to kilogram quantities have taught us that attention to purity and consistency makes real differences in peptide chain assembly. Many researchers and production managers often remark about trouble with byproduct peaks and microimpurities from other sources; these headaches can trace back to minor choices made during raw material control. We believe that straightforward sourcing, focused on stringent analytics from the outset, shapes the way Fmoc-protected amino acids, especially unusual stereochemical variants like D-configurations, behave in a synthesis workflow.

    What Defines Reliable Fmoc-D-Asparagine?

    Our Fmoc-D-Asparagine, offered under the common model abbreviation Fmoc-D-Asn-OH, comes with a proven track record in both research-scale and manufacturing settings. Customers often highlight low racemization rates in final peptide products and improved coupling efficiency, especially in sensitive sequences. The reason for this is rooted in precise control over chiral purity and moisture. Minute shifts in optical rotation or solvent content can lead to irreversible steps in solid phase syntheses. A product that holds steady from batch-to-batch reduces rework and unexpected clean-up phases—reality that any lab manager or organic chemist understands.

    Our process always starts with directly sourced asparagine of the D-configuration. We only move forward after evaluating optical purity well beyond baseline chiral specifications. The Fmoc-protection itself gets performed under scrupulously controlled temperature and atmospheric conditions. Many manufacturers will add the Fmoc group without accounting for ambient drift, but we watched yields fluctuate in our early years when this step wasn’t carefully standardized. We learned to limit acid or base traces and keep solvents fresh—avoiding aged or recycled batches known to introduce impurities. Our in-house analytics check for residual solvents, byproducts, and especially the unwanted L-isomer below the 0.5% level.

    Specifications: Designed for Synthesis Environments

    Fmoc-D-Asparagine purity reaches a minimum 98% by HPLC, and moisture is tightly regulated below 1%. Color and texture play roles too; material that clumps or discolors will stall dispensing machines. Each lot gets manually inspected for visual uniformity, and we keep moisture checks running until the final seal goes on. Every single gram is produced and packed in our own facility under constant nitrogen. We don’t hand off outside our walls or run drop-shipping. Our batch sizes typically range from multi-hundred gram to multi-kilogram, so whether you are preparing short model sequences or scaling to clinical peptides, the handling properties do not shift unpredictably between lots.

    The molecular weight sits at 410.42 g/mol, and the classic Fmoc-protection provides a recognized route for standard solid-phase and solution-phase synthesis, including Fmoc/tBu strategies and further orthogonal systems. Solubility comes easy in standard peptide solvents, including DMF and NMP. During actual automated synthesis cycles, we’ve received feedback that couplings involving our Fmoc-D-Asparagine require fewer repeats or extended times. This does not come from theoretical optimization; it’s an outcome of hard-won hands-on process improvement and direct engagement with customers doing real-world work.

    How Our Fmoc-D-Asparagine Stands Out from the Crowd

    Many amino acid manufacturers share similar baseline certificates, but day-to-day use exposes practical differences. D-isomer content poses hazards for both research reproducibility and large-scale manufacturing because undetected L-isomer presence can escape basic chiral HPLC and show up only after extended sequences or biological assays. After running side-by-side trials, a few contract manufacturing partners highlighted that our Fmoc-D-Asparagine provided cleaner LCMS results, with less ghosting and improved sequence confirmation downstream. Impurities sustained in microbatches often reappear in kilogram lots; we view this as a key risk, so we maintain constant monitoring at cross-lot intervals too, not just at the batch release stage.

    Protection group stability deserves special mention. The Fmoc group sometimes suffers from background cleavage, particularly in warmer or humid warehouse conditions. Distributors sometimes stock for months before onward resale, and analyst teams will notice increased background deprotection. All Fmoc-D-Asparagine leaving our floor gets refrigerated prior to dispatch, and we encourage partners to keep it cool and dry from arrival to weighing. This policy protects your workflow and supports high coupling efficiency across any scale.

    Applications: Meeting Real-World Synthesis Demands

    Fmoc-D-Asparagine finds its primary use in the synthesis of peptides containing D-amino acids—a critical aspect in the design of protease-resistant analogs, bioactive compounds, and structural probes. Pharmaceutical pipelines increasingly depend on D-configured amino acids to boost metabolic stability or enhance binding. Our product handles these specialized demands, including assembly of long, hydrophilic stretches and cyclic peptides. Several teams share that their early sequences failed due to incomplete coupling or asparagine deamidation; reliable Fmoc-D-Asparagine, managed with fresh desiccant and quick transfer under inert gas, helped clean up their synthesis flowcharts.

    Beyond basic research, our product also serves diagnostic, therapeutic, and even agrochemical sectors developing plant peptides with D-configuration for enhanced shelf life. University cores and biotech start-ups come to us for both small lots and larger volumes once pilot projects gain traction. Rather than focusing only on major pharmaceutical clients, we built our production lines to serve varied end-users, because the need for precise D-amino acid blocks keeps expanding.

    Addressing Routine Problems with Fmoc-D-Asparagine

    Peptide synthesis routines rarely proceed without snags. Fmoc-D-Asparagine can degrade to aspartic acid, carry over racemized L-forms, or introduce trace acyl transfer byproducts if the raw materials or handling slip below critical benchmarks. Years of technical support taught us to anticipate common stumbling blocks faced by end-users:

    To reduce these issues, every production run gets finished with in-line drying and HRMS verification. Shipping packs come with moisture-resistant linings, and we advise against prolonged exposure during weighing. These might seem like small steps, but on a day-to-day basis, preventing undetected asparagine deamidation greatly reduces post-purification headaches and lost time. In past collaborations, some peptide houses reported that after switching to our material, they cut their final HPLC purification time by as much as 30%. Every improvement helps under deadline pressure.

    From Bench to Pilot Plant: Handling and Workflow Insights

    Hand-charging amino acids, especially when scaling synthesis, brings its own set of challenges. Powder that spreads dust across the benchtop or refuses to dissolve evenly in DMF can back up an entire line of reactors. Our feedback channels remain open with technical teams in both academic and GMP settings, so formulation tweaks happen based on actual user reports. One group modifying antimicrobial peptides highlighted how a previous supplier’s Fmoc-D-Asparagine packed inconsistently, causing dosing inaccuracies on automated lines. We changed our sieving and drying procedure after this, resulting in a product that flows more easily, with less static and clumping.

    Some partners opt for customized packaging—such as pre-weighted aliquots for robotic systems—so the material meets automation needs as labs get busier. The science of peptide synthesis evolves quickly, but the need for predictable, high-quality building blocks remains the same. Recalls related to stereochemical mix-ups greatly compromise product pipelines and cause knock-on delays, so all of our Fmoc-D-Asparagine stays subject to cross-verification, including orthogonal chiral purity testing at random intervals.

    Strict environmental controls during both production and shipping contribute to longer product shelf life and a more manageable lab workflow. We routinely consult with peptide scientists who experienced setbacks with imported materials suffering degradation in customs or uncontrolled warehouses. Keeping all outgoing lots under nitrogen and rolling out a traceable cold chain for larger orders helps mitigate these risks. Cold, dry, and properly sealed—these simple points uphold quality from bench to pilot plant.

    Supporting Better Science with Direct Manufacturer Input

    Unlike trading companies or third-party sellers, manufacturers gain a front-row seat to emerging science by working side by side with end users. Continuous dialog with academic and industrial teams highlights evolving demands, such as the desire to reduce hazardous waste or lengthen peptide lifespan in real applications. We specially monitor for micro-impurities and handle raw D-asparagine in a closed system. We never rely on secondary finishing sites because even minor lapses introduce batch-to-batch drift years down the line. The journey from raw amino acid to finished Fmoc-D-Asparagine demands attention to both process yield and practicality for the user in the lab.

    Suppliers who manufacture in-house routinely catch early drift in isomeric ratio, moisture, or color—fixes that don’t make it into after-the-fact reports when relying on distant toll processors. Chemists out at the bench often won’t notice slight off-spec batches until consistency slips in larger sequences. Our facility keeps all critical controls—heating, solvent volume, drying, and sample splitting—directly under one roof, ensuring that every gram reaching the end user reflects the same reliable starting materials. Our analytics go beyond the certificate; we often invite users to visit, observe our line, or review original data for their exact batch.

    Trust Through Traceability and Transparency

    Peptide synthesis runs on fine margins, both in budget and yield. Confidence in every bottle calls for more than routine documentation—it means traceability through the whole production and QC process. Each bottle and drum gets its lot code and a chain-of-custody history maintained from raw input through final packaging. We welcome technical queries, and can provide detailed supporting data for any production campaign, down to impurity mapping or cross-batch chiral HPLC overlays. GMP projects and regulated studies draw especially on these controls, since ambiguity about building block history can derail years of clinical work.

    Large pharmaceutical clients and up-and-coming biotech spinouts both face stringent regulatory demands for synthetic inputs. We remain committed to full transparency, sharing detergent-wash records and environmental monitor logs, not just final COAs. End-users facing regulatory, patient-facing, or preclinical studies can request targeted impurity analyses or even hold sample reserves for future re-testing.

    Environmental and Safety Concerns—Addressing Directly

    Amino acid manufacture and protection chemistry raise some valid safety and waste challenges. Fmoc chemistry, by design, involves repeated use of organic solvents and excess reagents—if left unchecked, waste piles up and occupational safety may slip. Our own operations evolved over the years to use fresh solvent only at the most critical step, and all Fmoc-activation waste streams get treated in closed-loop systems. Off-site disposal follows local chemical protocols, but in-house neutralization reduces offgassing and chemical carry-over to near zero. Staff training stays up-to-date on PPE and iso-zone handling. These steps not only protect workers but also directly improve end product quality, as less environmental humidity and fewer fugitive vapors sneak into finished batches.

    Customers worried about environmental impact often ask about solvent balance or alternatives. For now, DMF, NMP, and dichloromethane remain necessary for optimal product, but our process development chemists continually scan for lower-impact routes, with pilot trials under way for new solvents or recyclable supports. End-users benefit most when we work openly on process sustainability, and we encourage open conversations on safe disposal and green alternatives.

    Our Commitment: Reliable Fmoc-D-Asparagine from a Manufacturer's Perspective

    Quality peptides start with quality building blocks—that simple rule holds as much for basic R&D as for scale-up production. We know that delays in synthesis or purification setbacks can compound quickly, especially if traced back to inconsistent sources or undisclosed third-party toll production. By keeping manufacturing under our own roof, we stand behind every batch and draw on user feedback to identify and address new technical barriers quickly.

    Research trends change and clinical needs evolve; D-amino acid building blocks like Fmoc-D-Asparagine only gain value as new applications arise in bioactive and therapeutic peptide pipelines. Our ongoing investment in analytics, process control, and technical support reflects the needs of researchers working to move science forward every day. Direct manufacturer relationships foster innovation—not just in product, but in service and open dialog with the scientific community. Good chemistry is built on trust, and that trust starts at the source.